SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-019129
Filing Date
2019-05-14
Accepted
2019-05-14 16:04:29
Documents
3
Period of Report
2019-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K EARNINGS acer-8k_20190514.htm 8-K 35040
2 EX-99.1 acer-ex991_41.htm EX-99.1 144085
3 GRAPHIC g23nglp0heu3000001.jpg GRAPHIC 2729
  Complete submission text file 0001564590-19-019129.txt   184506
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 19822669
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1